Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Follow us
Alexa global traffic share
Latest investments Show all
CAD $24,000,000
Venture capital (Series A)
Optina Diagnostics
$29,000,000
Venture capital (Series A)
Libra Therapeutics
Team Size
1–10
Employees
Location
Headquarters
Past year's investments

Boehringer Ingelheim Venture Fund participated in fewer than 3 rounds over the past year

Latest rounds
  • Optina Diagnostics: Venture capital (Series A) (CAD $24M)
  • Libra Therapeutics: Venture capital (Series A) ($29M)
  • bodyport: Venture capital (Series A) ($11.2M)